课题基金 / 基金详情

New cancer therapy by degradation of specific proteins

New cancer therapy by degradation of specific proteins
通过降解特定蛋白质的新癌症疗法
批准号:
13557019
负责人:
NAKAYAMA Keiichi
金额:
$9.02万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002

项目摘要

项目成果

NAKAYAMA Keiichi的其他基金

相关文献

中文摘要
翻译
我们提出通过修饰泛素连接酶来诱导特定蛋白的降解,最近有报道称许多蛋白的表达水平不仅受转录调控,而且受降解率调控。泛素-载体体系统因其特异性而成为调控蛋白表达水平的重要系统之一。在这个独特的点上,我们试图创造新的泛素连接酶来识别和诱导降解对我们身体有毒的蛋白质。在这个项目中,我们使用癌蛋白Myc作为模型蛋白。由于已知Myc与Max结合,我们制作了几个嵌合蛋白,Max/Nedd4, Max/b-TrCP1, Max/CHIP。ned4是一种hect型泛素连接酶。b-TrCP1是一种F-box蛋白,是scf型泛素连接酶的一个组成部分。CHIP是一种u型泛素连接酶。据推测,Myc会被这些嵌合蛋白结合并泛素化。我们在体外系统和体内免疫沉淀实验中证实了该人工蛋白Max/CHIP与Myc的结合。通过表达载体过表达Max/CHIP蛋白能最有效地降低Myc在哺乳动物细胞中的半衰期。斑块实验和集落形成实验表明,Max/CHIP嵌合蛋白的表达抑制了myc诱导的转化。现在,我们观察对整个身体的影响。我们将过表达Max/CHIP嵌合蛋白的肿瘤细胞植入裸鼠体内,观察其对肿瘤发生的影响。
英文摘要
We proposed to induce to degradation of specific protein by the modification of ubiquitin-ligase, Recently, it is reported that expression level of many proteins are regulated by not only transcription but degradation rate. Ubiquitin-porteasome system is one of the most useful system to regulate expression level of protein because of its specificity. On this unique point we try to create new ubiquitin-ligase to recognize and induce to degradate proteins which are toxic for our bodies.In this project, we used oncoprotein, Myc as model protein. Because Myc is known to bind to Max, we made several chimeric proteins, Max/Nedd4, Max/b-TrCP1, Max/CHIP. Nedd-4 is a HECT-type ubiquitin-ligase. b-TrCP1 is a F-box proteins which is a component of SCF-type ubiquitin-ligase. CHIP is a U-box type ubiquitin-ligase. It was hypothesized that Myc would be bound and ubiquitylated by these chmeric proteins.We confirmed that this artificial protein Max/CHIP bound to Myc in vitro system and also immunoprecipitation assay in vivo. The half-life of Myc reduced by overexpression of Max/CHIP protein in mammalian cells by expression vector most efficiently.Plaque assays and colony-formation assay shown that Myc-induced transformation is inhibited by Max/CHIP chimeric protein expression.Now, we observe the effect on whole bode. We implanted tumor cells which overexpressed Max/CHIP chimeric protein in Nude mouse to examine the effect of tumorigenesis.
期刊论文(132)
专著(0)
科研奖励(0)
会议论文
Kanematsu, T. et al.: "Role of the PLC-related, catalytically inactive protein p130 in GABA_A receptor function"EMBO J.. 21. 1004-1011 (2002)
Kanematsu, T. 等人:“PLC 相关的催化失活蛋白 p130 在 GABA_A 受体功能中的作用”EMBO J.. 21. 1004-1011 (2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shimoda K. et. al.: "Tyk2 is required for the induction and nuclear translocation of Daxx which regulates IFN-α-induced suppression of B lymphocyte formation"J. Immunol.. 169. 4707-4711 (2002)
Shimoda K. 等人:“Tyk2 是 Daxx 的诱导和核易位所必需的,它调节 IFN-α 诱导的 B 淋巴细胞形成抑制”J.Immunol.. 169. 4707-4711 (2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nagahama, H.: "Spatial and temporal expression patterns of the cyclin-dependent kinase (CDK) inhibitors p27^<Kip1> and p57^<Kip2> during mouse development"Anat. Embryol. 203. 77-87 (2001)
Nagahama, H.:“小鼠发育过程中细胞周期蛋白依赖性激酶 (CDK) 抑制剂 p27^<Kip1> 和 p57^<Kip2> 的空间和时间表达模式”Anat。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shimoda K. et al.: "Tyk2 is required for the induction and nuclear translocation of Daxx which regulates IFN-α-induced suppression of B lvmphocvte formation"J. Immunol. I. 169. 4707-4711 (2002)
Shimoda K. 等人:“Tyk2 是 Daxx 的诱导和核转位所必需的,Daxx 调节 IFN-α 诱导的 B 淋巴细胞形成抑制”J.Immunol.169.4707-4711 (2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 39 条
    Elucidation of Warburg effect in cancer with the next-generation proteomics
    • 批准号:
      26640080
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2014
    • 负责人:
      NAKAYAMA Keiichi
    • 依托单位:
    Deciphering the role of protrudin regulating neuronal vesicular transport
    • 批准号:
      22240038
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $31.95万
    • 财政年份:
      2010
    • 负责人:
      NAKAYAMA Keiichi
    • 依托单位:
    Deciphering the mechanisms underlying cancer development induced by deregulation of proteolysis
    • 批准号:
      17013067
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $30.46万
    • 财政年份:
      2005
    • 负责人:
      NAKAYAMA Keiichi
    • 依托单位:
    Isolation and characterization of protrudin, a master regulator of neurite formation
    • 批准号:
      17107004
    • 项目类别:
      Grant-in-Aid for Scientific Research (S)
    • 资助金额:
      $71.47万
    • 财政年份:
      2005
    • 负责人:
      NAKAYAMA Keiichi
    • 依托单位: